News Releases

Explore all the latest news from Johnson & Johnson Vision around the globe.*

Acuvue
Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen – World’s First and Only Drug-Eluting Contact Lens

Novel technology combines ACUVUE® daily disposable contact lenses with an established antihistamine in FDA- first in its new category 

JACKSONVILLE, FL –March 2, 2022…

Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE® Theravision™ with Ketotifen – World’s First and Only Drug-Eluting Contact Lens
Abiliti
JOHNSON & JOHNSON VISION LAUNCHES ACUVUE ABILITI™ - A NEW BRAND OF MYOPIA MANAGEMENT SOLUTIONS TO HELP CONTROL CHILDREN’S MYOPIA

Abiliti™ aims to give children clearer vision today for better eye health tomorrow through innovative and scientifically-proven solutions

SINGAPORE, 20 January 2022 – Johnson…

JOHNSON & JOHNSON VISION LAUNCHES ACUVUE ABILITI™ - A NEW BRAND OF MYOPIA MANAGEMENT SOLUTIONS TO HELP CONTROL CHILDREN’S MYOPIA
abiliti
Johnson & Johnson Vision Introduces ACUVUE® Abiliti™ to Address the Growing Prevalence of Myopia

JACKSONVILLE, FL – April 21, 2021 – Johnson & Johnson Vision,* a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies,† today announced…

Johnson & Johnson Vision Introduces ACUVUE® Abiliti™ to Address the Growing Prevalence of Myopia

Feature Stories

Johnson & Johnson Media Center

For more information about the latest Johnson & Johnson
news and publications visit the Media Center at www.jnj.com

Johnson & Johnson Media Center

Social Media LIVE

 

*Johnson & Johnson Vision medical device information contained in the News Releases are specific to the market highlighted and is not intended for dissemination outside the intended market.

PP2023OTH5448